Press release
Meningococcal Vaccines Market to Garner Brimming Revenues by 2021
Based on various cause of the disease, meningitis is classified into two main types: non-infectious meningitis and infectious meningitis. Non-infectious meningitis is a type of aseptic meningitis. Aseptic meningitis is caused by something other than the bacteria that typically cause acute meningitis. Non-infectious meningitis does not spread from person to person. Infectious meningitis is further sub-divided into bacterial meningitis, fungal meningitis, viral meningitis and parasitic meningitis. Bacterial meningitis is extremely severe form of the disease which is caused by bacteria such as Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumonia. These bacteria can spread from person to person through coughing and sneezing. Viral meningitis is mainly occurred by diarrhea causing virus. Fungal meningitis is rare in healthy people. However, person who has an impaired immune system is more prevalent with this form of the disease.
View Report Preview @ https://www.persistencemarketresearch.com/market-research/meningococcal-vaccines-market.asp
Septicemia arises from infections throughout the body. It includes infections in the lungs, urinary tract and abdomen. Meningococcemia is also caused by bacterium Neisseria meningitidis.
The global meningococcal vaccines market is segmented into conjugate vaccines, polysaccharide vaccines and combination vaccines. Conjugate vaccines reduce incidences of bacterial meningitis. This is due to prolonged immunization influence of the vaccine which is developed for various serogroups of bacteria. Major brands of conjugate vaccines include MenAfriVac, Nimenrix, Menactra, Meningitec, NeisVac-C and Menveo.
Polysaccharide provides immunity for a short period of time. Major brands of polysaccharide vaccines include NmVac4, Menomune, Bi Meningo, Mencevax and Quadri Meningo.
Combination vaccines are prepared with the combination of other microorganism. Major brands of combination vaccines include Menitorix and MenHibrix.
Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/3640
In terms of geographic, North America dominates the global meningococcal vaccines market. This is due to increased healthcare awareness in the region. The U.S. represents the largest market for meningococcal vaccines followed by Canada in North America. In Europe, France, Germany and the U.K. holds major share of meningococcal vaccines market. However, Asia is expected to show high growth rates in the next five years in global meningococcal vaccines market. This is due to increasing awareness among people about meningitis in the region. Several government associations have launched various immunization programs and awareness campaigns to provide education about meningococcal disease. Japan, China and India are expected to be the fastest growing meningococcal vaccines markets in Asia.
In recent time, increased government support is key driver for the global meningococcal vaccines market. Various government associations have launched mandate immunization programs for school children. This increases the demand of meningococcal vaccines to provide immunity against meningococcal disease.
However, stringent regulations hamper the growth of global meningococcal vaccines market. Increasing mergers and acquisitions between manufacturing companies and government bodies and rapid product launches are some of the major trends of global meningococcal vaccines market.
Some of the major companies operating in the global meningococcal vaccines market are GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG, Sanofi SA, Pfizer, Inc. and Baxter International, Inc..
Buy now @ https://www.persistencemarketresearch.com/checkout/3640
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market to Garner Brimming Revenues by 2021 here
News-ID: 845228 • Views: …
More Releases from Persistence Market Research
Bicycle Spokes Market Set for Strong Growth at 5.4% CAGR Through 2032 - Persiste …
The global bicycle spokes market is rapidly gaining traction as bicycles continue to be adopted as preferred choices for commuting, fitness, recreation, and eco‐friendly mobility. The global bicycle spokes market size is likely to be valued at US$2.9 billion in 2025 and is expected to reach US$4.2 billion by 2032, registering a steady CAGR of 5.4 % between 2025 and 2032.
➤ Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/30615
Bicycle…
Herbal Toothpaste Market Growth Poised at 6.5% CAGR Through 2033 Amid Rising Hea …
The global oral care industry is undergoing a transformational shift as consumers increasingly prioritize natural, chemical free alternatives. Central to this transformation is the herbal toothpaste market, which is rapidly emerging as a mainstream segment driven by rising health consciousness, sustainability trends, and demand for botanical formulations. The global herbal toothpaste market size is likely to be valued at US$ 2.6 billion in 2026 and is projected to reach US$…
Dead Sea Mud Cosmetics Market Set for Steady Expansion Amid Rising Demand for Na …
The global beauty and personal care industry continues to evolve as consumers shift toward natural, mineral-based, and wellness-oriented skincare solutions. Among these, Dead Sea mud cosmetics have gained strong traction for their mineral content and perceived therapeutic benefits. According to industry estimates, the global dead sea mud cosmetics market is likely to be valued at US$1.5 billion in 2026 and is projected to reach US$2.3 billion by 2033, expanding at…
Retail Glass Packaging Market Projected to Reach US$77.0 Billion by 2032 at 5.3% …
The retail glass packaging market continues to play a crucial role in the global packaging ecosystem, particularly across food, beverage, cosmetics, and pharmaceutical retail channels. Glass packaging remains a preferred solution due to its premium appearance, chemical inertness, recyclability, and ability to preserve product integrity. As consumers increasingly prioritize sustainability, safety, and high quality packaging, retail glass packaging has regained strategic importance across both developed and emerging economies. Brands are…
More Releases for Meningo
Meningococcal Vaccines Market to Cross US$ 4.4 Billion Globally by 2022
New York, April 24: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Global Meningococcal Vaccines Market by Combination-, Conjugate-, Polysaccharide …
The global meningococcal vaccines market is estimated to reach US$ 4.3 Bn in 2021, expanding at a CAGR of 12.6% from 2017 to 2021, due to technological advancement and its rapid adoption worldwide.
Browse Meningococcal Vaccines Market by Meningococcal Combination Vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal Conjugate Vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); and Meningococcal Polysaccharide Vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo) and Forecast 2017-2021…
Meningococcal Vaccines Market Worth US$ 4.4 Billion Globally by 2022
New York, April 06: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Exceed US$ 4.4 Billion by 2022
New York, March 16: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Reach US$ 4.4 Billion by 2022
New York, March 08: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Cross US$ 4.4 Billion by 2022
New York, February 27: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
How Big is the Global Meningococcal Vaccines Market?
The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.4 billion by 2022 and will grow at a CAGR of more…
